Status:
COMPLETED
To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Cirrhosis, Liver
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
Children with cirrhosis awaiting transplantation are more proned to develop various complications. The pathogenesis of cirrhotic complications (ascites, hyponatremia, acute kidney injury) includes rel...
Detailed Description
Aim: To determine the efficacy of midodrine in preventing development of complications in children with cirrhosis awaiting liver transplantation Primary Objective: 1\) To compare incidence of compli...
Eligibility Criteria
Inclusion
- Children and Adolescents of age group upto 18 years with cirrhosis and PELD/ MELDNa score more than 14, on waitlist for liver transplantation following up in the Pediatric Hepatology Department, ILBS will be prospectively included in this study after informed consent
Exclusion
- Presence of Portal vein thrombosis Renal or cardiovascular disease or arterial hypertension Presence of HCC
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05287100
Start Date
January 1 2022
End Date
May 30 2023
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of liver and biliary sciences
New Delhi, India, 110070